SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-22-002165
Filing Date
2022-02-10
Accepted
2022-02-10 07:30:41
Documents
9
Period of Report
2022-02-10

Document Format Files

Seq Description Document Type Size
1 6-K cybininc-form6xk1112workiv.htm 6-K 21915
2 EX-99.1 cybinincfs-q3x22xdec312021.htm EX-99.1 542056
3 EX-99.2 cybin-mdaq3xdecember312021.htm EX-99.2 838851
4 EX-99.3 q32021-cfocertificatecybin.htm EX-99.3 12818
5 EX-99.4 q32021-ceocertificatecybin.htm EX-99.4 13059
6 EX-99.5 q322earningsprv9clean002.htm EX-99.5 25916
7 capture.jpg GRAPHIC 29252
8 image_0.jpg GRAPHIC 21272
9 capturea.jpg GRAPHIC 29252
  Complete submission text file 0001628280-22-002165.txt   1555011
Mailing Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9
Business Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9 (908) 764-8385
CYBIN INC. (Filer) CIK: 0001833141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-40673 | Film No.: 22609584
SIC: 2834 Pharmaceutical Preparations